Abeona Therapeutics (NASDAQ: ABEO) announced a license agreement with Stanford University for an AAV (adeno-associated virus) delivery vector for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE